{'fraction_non_alphanumeric': 0.02785923753665689, 'fraction_numerical': 0.005865102639296188, 'mean_word_length': 5.324074074074074, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Letter by Amat-Santos et al Regarding Article, "Atrial Fibrillation Is Associated With Increased Mortality in Patients Undergoing Transcatheter Aortic Valve Replacemen: Insights From the Placement of Aortic Transcatheter Valve (PARTNER) Trial".

We read with great interest the article from Biviano et al.1 We think that their findings are of utmost importance for the prognostic assessment of patients following transcatheter aortic valve replacement. In this study, the rate of new-onset atrial fibrillation (AF) as reported in the ECG performed at discharge was 6%. This rate is low in comparison with previously reported research,2,3 especially if we consider the high rate of …